Lewis Karen
SEC insider (Form 3/4/5 filer). CIK 0001814304. Chief People Officer at Apellis Pharmaceuticals, Inc. (APLS). 5 reported Form 4/5 transactions since Sep 2024; latest on Jan 29, 2025. Located in WALTHAM, MA.
Companies Lewis Karen has filed insider reports for
- Apellis Pharmaceuticals, Inc. (APLS): Officer, Chief People Officer
Lewis Karen
CIK: 0001814304
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)4 (80.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (20.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
APLS
Apellis Pharmaceuticals, Inc.
Officer
Discretionary Trading P&L
Holdings
Transaction History (5 total)
- Jan 29, 2025APLS
Apellis Pharmaceuticals, Inc.
SaleDirect364 shares at avg. $29.52$11K - Jan 22, 2025APLS
Apellis Pharmaceuticals, Inc.
SaleDirect1.8K shares at avg. $30.43$53K - Jan 21, 2025APLS
Apellis Pharmaceuticals, Inc.
AwardDirect28.5K shares- - Jan 17, 2025APLS
Apellis Pharmaceuticals, Inc.
SaleDirect1.2K shares at avg. $29.96$37K - Jan 13, 2025APLS
Apellis Pharmaceuticals, Inc.
SaleDirect1.6K shares at avg. $28.70$46K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jan 29, 2025 | APLS Apellis Pharmaceuticals, Inc. | Sale | 364 | $29.52 | $10,747 | Direct |
| Jan 22, 2025 | APLS Apellis Pharmaceuticals, Inc. | Sale | 1,751 | $30.43 | $53,275 | Direct |
| Jan 21, 2025 | APLS Apellis Pharmaceuticals, Inc. | Award | 28,508 | - | $0 | Direct |
| Jan 17, 2025 | APLS Apellis Pharmaceuticals, Inc. | Sale | 1,241 | $29.96 | $37,178 | Direct |
| Jan 13, 2025 | APLS Apellis Pharmaceuticals, Inc. | Sale | 1,599 | $28.70 | $45,895 | Direct |
1-5 of 5 transactions